We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
AusPAR: Adalimumab (rch)
Australian Public Assessment Report
Device/Product Name
Humira
Active ingredients
Adalimumab (rch)
AusPAR Date
Published
Sponsor
Submission Number
PM–2014-04326-1-4
Submission Type
Major variation; extension of indications
Decision
Approved